Kahn Brothers Group Inc – PFE history
- Issuer:
- Pfizer
- Quarters tracked:
- 10 (Q4 2023 → Q1 2026)
- Current shares:
- 484,733
- Current value:
- $13.61M
- Peak shares:
- 1,025,681 (Q4 2023)
- Overall change:
- -53%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 484,733 | $13.61M | $28.08 | -69,217 | -12% |
| Q4 2025 | 553,950 | $13.79M | $24.90 | -153,194 | -22% |
| Q3 2025 | 707,144 | $18.02M | $25.48 | -23,845 | -3% |
| Q2 2025 | 730,989 | $17.72M | $24.24 | -4,200 | -1% |
| Q1 2025 | 735,189 | $18.63M | $25.34 | -25,901 | -3% |
| Q4 2024 | 761,090 | $20.19M | $26.53 | -235,935 | -24% |
| Q3 2024 | 997,025 | $28.85B | $28939.88 | -5,405 | -1% |
| Q2 2024 | 1,002,430 | $28.05B | $27979.80 | -20,289 | -2% |
| Q1 2024 | 1,022,719 | $28.38B | $27749.76 | -2,962 | 0% |
| Q4 2023 | 1,025,681 | $29.53B | $28790.26 | — | NEW |